© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Timolol Maleate (S-Form) belongs to the beta-blocker category of chemicals, often used in pharmaceutical research and, more specifically, in the production of medications for glaucoma or hypertension. As a precise single-enantiomer substance, the S-Form reflects purposeful engineering at the molecular level to shape its bioactive characteristics. Focusing on the S-Form ensures greater selectivity and specific biological effects, which translates into more controlled outcomes during both research and medical use. Steering away from racemic mixtures means manufacturers and researchers can count on reliable, repeatable results, especially where even minor unwanted byproducts can shift safety profiles.
As a raw material, Timolol Maleate (S-Form) generally comes as an off-white to pale yellow crystalline powder, though appearances may shift depending on supplier, purification methods, and environmental factors in storage. This solid remains dry and stable at room temperature, typically forming small, flaky crystals or fine powder. Some suppliers offer options like larger flakes, pearlized grains, or compressed dense powder for specific batching needs, but the basic molecular backbone does not change. With a density hovering close to 1.1 g/cm³ under laboratory conditions, its reliable composition is a trademark for batch testing and precise pharmaceutical compounding. Moisture matters here: even slight humidity can cause clumping or change the tactile feel of the substance, so sealed packaging remains essential from warehouse to laboratory.
Timolol Maleate (S-Form) features the chemical formula C13H24N4O3S·C4H4O4, pairing a selective beta-adrenergic receptor antagonist (Timolol, C13H24N4O3S) with maleic acid (C4H4O4) to stabilize and solubilize the formulation in pharmaceutical preparations. Its molecular weight rests around 432.5 g/mol, a measured parameter for formulation scientists calculating proper concentrations for injection or ophthalmic solutions. Researchers often talk about chirality and stereoselectivity, but the “S-Form” badge puts a real-world stamp on the molecule’s spatial arrangement. Stereochemistry holds power: it influences everything from solubility and bioavailability to how easily enzymes and receptors in the human body interact with the material. Understanding this property saves companies money, streamlines FDA or EMA registration, and does a world of good for quality assurance teams tasked with verifying compound identity batch after batch.
Safe handling starts in the warehouse, not the lab. Timolol Maleate (S-Form) shouldn’t sit open to air, as exposure to atmospheric moisture leads to caking or subtle degradation. Good practice calls for dry, well-sealed containers, stored away from direct sunlight, in rooms kept below 30°C. Eye shields and gloves are non-negotiable for technicians measuring or batching this chemical. Inhalation or accidental ingestion can cause harm due to its beta-blocking properties, which, in pharmaceutical concentrations, may spark unintended cardiovascular or respiratory depression. Every container holds clear labeling as hazardous—Class 6.1 (toxic substances) per the United Nations Globally Harmonized System (GHS)—making shipment and customs paperwork time-consuming but absolutely necessary. Proper ventilation and PPE save lives and keep cleanup headaches at bay if spills occur. Training on chemical spill kits—absorbent pads, neutralizing agents, protective gowns—proves worth every hour spent in onboarding.
Manufacturers ship Timolol Maleate (S-Form) in drums or vials, usually in quantities ranging from a few grams for R&D to industrial batches exceeding 10 kilograms. Some buyers request custom-milled powders to suit automated dispensing systems or favor crystalline forms for enhanced purity. Dissolving the powder for use in laboratory or clinical trials often means blending it with precise volumes of sterile water or buffered saline, achieving target concentrations accurate to a tenth of a milligram per milliliter. Consistency in solution clarity and pH tells quality control teams the product meets or exceeds target specs. Filtration through 0.22-micron membranes keeps solutions free of particulates, meeting the highest standards for parenteral or ophthalmic compounding. In storage, finished solutions need refrigeration and protection from microorganisms, sometimes with additional preservatives added based on shelf-life studies published in peer-reviewed journals. Feedback from compounding pharmacists has shaped these prep routines, tightening up protocols to stop wasted product and guarantee every drop dispensed hits target potency.
Timolol Maleate (S-Form) carries the Harmonized System (HS) Code 2934999090, classified among “Other heterocyclic compounds containing an unfused pyrazole ring.” This code determines tariff levels, customs tracking, and regulatory compliance from origin to destination country. Logistics teams know customs authorities flag chemicals with potential hazardous properties, so linking shipment documents to proper Safety Data Sheets (SDS), Certificates of Analysis (COA), and Transport Emergency Cards smooths the path from supplier to end user. International buyers face different notification requirements—Europe’s REACH and the United States’ EPA and DEA all maintain their own approval checklists. That mountain of paperwork builds trust across the supply chain, protecting recipients and final end-users from surprises in storage, handling, or clinical application.
Consistency, above all, drives demand for precisely manufactured Timolol Maleate (S-Form). Pharmaceutical companies, compounding centers, and university research labs want every lot to match exacting standards for purity, density, and stability. Cutting corners here means risking patient care or setting back whole R&D programs with batch-to-batch variance. Problems surface quickly if purchasing, QC, or warehouse management slips—for example, storing powder in conditions where undetected moisture uptake threatens downstream formulation. Companies that invest in best practices—real-time monitoring, advanced moisture-barrier packaging, automated batch testing—see long-term savings both in product yield and regulatory compliance. Shared experience across the industry suggests that direct supplier relationships based on published, peer-reviewed quality data set the gold standard. Collaboration, not secrecy, between procurement, regulatory affairs, and end users rolls back errors and speeds new formulations to market.
